This content is only available within our institutional offering.

13 Apr 2023
Hikma Pharmaceuticals (HIK.L, 2,210p, Buy) (Results Review) - Updating forecasts: no material changes, but TP rises 60p

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Hikma Pharmaceuticals (HIK.L, 2,210p, Buy) (Results Review) - Updating forecasts: no material changes, but TP rises 60p
Hikma Pharmaceuticals Plc (HIK:LON) | 1,749 122.4 0.4% | Mkt Cap: 3,881m
- Published:
13 Apr 2023 -
Author:
Miles Dixon | Edward Sham -
Pages:
14 -